The next event in our Additive Manufacturing Advantage (AMA) focuses on the use of 3D printing in healthcare.
AMA: Healthcare 2026 will bring together leading voices in medical, dental, pharmaceutical, and regenerative manufacturing to examine how additive manufacturing is moving from specialist use cases toward scalable healthcare production.
Our free online event on June 4th will explore how 3D printing is reshaping the development of patient-specific devices, prosthetics, biodegradable implants, in vitro models, pharmaceutical applications, and future biofabricated organs. Sessions will address both the technical frontier and the practical realities of adoption, including advanced biomaterials, distributed manufacturing, quality management, MDR compliance, scalable workflows, and the regulatory pathways needed to bring innovation safely into clinical and industrial use.
Speakers include experts from Incus, TNO Holst Centre, ARPA-H, Newcastle University, Victoria Hand Project, Trabtech, Glidewell, and Not a Robot Engineering, covering topics from 3D printed prosthetics in low-income communities and organ biofabrication to dental production, gut-joint axis models, implicit scaffolds, and next-generation medical manufacturing.
Together, the sessions will offer a grounded view of where healthcare additive manufacturing stands today, where it is heading next, and what must happen for the technology to deliver meaningful impact at scale.
Register now to attend AMA: Healthcare 2026, and please share the event with colleagues or contacts looking to learn more about medical additive manufacturing and expand their industry network.
Confirmed speakers for AMA: Healthcare 2026
These are the speakers confirmed for this year’s event; more speakers will be added shortly.
Gerald Mitteramskogler, CEO, Incus GmbH
Gerald Mitteramskogler is the CEO and founder of Incus GmbH in Vienna. After earning his PhD in Mechanical Engineering at TU Vienna, he worked at Lithoz GmbH, where he contributed to research projects in additive manufacturing. Building on this experience, he founded Incus in 2019 to develop and industrialize Lithography-based Metal Manufacturing (LMM). Under his leadership, the company has grown into a recognized technology provider, advancing metal 3D printing from research to industrial production.
Kjeld van Bommel, Program Manager 3D Pharma Printing, TNO Holst Centre
Kjeld obtained his PhD in Supramolecular Chemistry in 2000 from Twente University (the Netherlands). He has been working at TNO since 2006 and has been active in the 3D printing space since 2010, initially focusing on 3D Food Printing and later 3D Pharma Printing. He is currently a Program Manager at the TNO Holst Centre.
Ryan Spitler, Program Manager, Advanced Research Projects Agency – Health
Dr. Ryan Spitler joined ARPA-H in November 2023 from Stanford University, where he served as founding deputy director of the Precision Health and Integrated Diagnostics Center. Spitler has over 20 years of experience working in health areas ranging from medical devices to the life sciences. He is a serial entrepreneur and cofounder of a health care and life science venture fund.
In addition to executive training from Stanford University’s School of Business, Spitler holds a doctorate in cellular and developmental biology from the University of California, Irvine, completed postdoctoral research in medical imaging and synthetic biology at Stanford University School of Medicine, and has served as teaching faculty at the Stanford Byers Center for Biodesign. His work has led teams in the development of smarter monitoring and diagnostic technologies to improve early detection and treatment of disease.
Priscila Melo, Lecturer in Bioengineering, Newcastle University
Dr Priscila Melo is a Lecturer in Bioengineering at Newcastle University (U.K.) whose research involves the development of new biomaterials for applications within Tissue Engineering and Regenerative Medicine, spanning from glass ceramics to collagen, as bioinks or even injectables.
She holds a PhD in Additive Manufacturing (AM) which is the foundation of her current work in Bioprinting where she explores the potential of different processes (e.g., extrusion printing and volumetric light projection) to create 3D in vitro models of several tissues (synovium, gut, myocardium), or regeneration platforms for bone and cartilage. Despite being an early career researcher (ECR), she co-manages the Tissue Engineering Laboratory housing all Bioprinting activities and tissue culture within the School of Engineering, and one of the board directors of the Newcastle University Centre for Research Excellence in Biomedical Engineering, and the leader of its ECR network.
Erik Boelen, Founder, Qase3D
Dr. ir. Erik Boelen is a biomedical engineer with a PhD in biomaterials and 20 years of experience in medical 3D printing. His career began at 3D printing leader Materialise, where he held various strategic roles in product development, marketing, and sales. He then spent nearly a decade as the COO at Xilloc Medical, where they pioneered some of the world’s first patient-specific 3D printed medical devices. Currently, he is the founder of Qase3D, a consultancy specializing in medical 3D printing and quality management, helping 3D printing companies and hospital labs achieve ISO 13485 certification and MDR compliance.
Michael Peirone, CEO, Victoria Hand Project
Michael Peirone is the CEO of the Victoria Hand Project (VHP), a Canadian charity providing 3D-printed prosthetic arms to amputees in low-resource settings. His involvement began as an undergraduate researcher while studying Biomedical Engineering with a Mechanical Engineering specialization at the University of Victoria.
Michael has extensive experience in designing prosthetic devices and workflows tailored for local manufacturing. Under his leadership, VHP has successfully implemented and expanded programs in countries including Ukraine, Nepal, Kenya, and Egypt, focusing on empowering local clinicians with the technology and skills to provide life-changing care.
Kuntay Aktas, CEO, Trabtech
Kuntay Aktas is the CEO of Trabtech, a company focused on advanced manufacturing technologies and additive manufacturing solutions for healthcare, dental, and high-performance industrial applications.
With extensive experience in digital manufacturing, industrial-scale additive manufacturing, and healthcare production workflows, he works at the intersection of technology commercialization and real-world manufacturing implementation. His work focuses on helping healthcare and manufacturing organizations adopt scalable additive manufacturing technologies for next-generation production.
Kuntay has been actively involved in the development of additive manufacturing ecosystems across dental production, medical devices, tooling, and advanced engineering applications. He frequently collaborates with global technology partners and manufacturers on topics including production scalability, advanced materials, automated quality control, and the future of patient-specific manufacturing.
Ankush Venkatesh, Intrapreneur, Additive Manufacturing, Glidewell
Ankush Venkatesh is the Intrapreneur, Additive Manufacturing at Glidewell, specializing in digital manufacturing, mass customization, and business strategy.
In addition to writing for Harvard Business Review, Forbes, Ankush has also been a speaker at the largest 3D printing events in the world, including Rapid+ TCT, Formnext, Additive Manufacturing Strategies (AMS), and Computational Design for Additive Manufacturing (CDfAM).
Ankush leads initiatives ranging from Digital Transformation to Product Development, to Commercial Partnerships, to shaping the future of 3D Printing in Dentistry. He’s also part of the American Dental Association’s (ADA) Standards Bodies for 3D/Advanced manufacturing in the dental industry.
Ankush’s past includes two years at the Tuck School of Business at Dartmouth College as a Strategy Fellow, focusing on digital manufacturing strategy as a management consultant for organizations adopting digital technologies for manufacturing.
Matthew Shomper, Principal Engineer, Not a Robot Engineering
Matthew is a visionary leader in the computational design of advanced 3D-printed medical implants, with close to 15 years of experience in engineering, research, and innovation. As an inventor, creator, and passionate leader, he has been a part of founding businesses focused on additive manufacturing and is an internationally recognized speaker on biomimicry, computational modeling, and additive manufacturing – lecturing at conferences and prestigious universities worldwide. Matthew’s work is driven by his passion for exploring the macro and micro of biological forms, turning algorithms into functional structures for physical devices. He has pioneered the idea of a “biologically advantageous implant,” and has also spearheaded multiple public initiatives to synthesize biological structures as computational models for use in engineered products. He is currently the founder and principal consultant of Not a Robot Engineering and is involved in several other stealth startups.
Register now to learn from healthcare AM leaders and expand your network across medical, dental, pharma, and regenerative manufacturing.
